PF 07999415
Alternative Names: PF-07999415Latest Information Update: 04 Jul 2025
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 14 May 2025 Pfizer plans a phase I trial (In volunteers) (SC), in May 2025 (NCT06965465)
- 11 May 2025 Preclinical trials in Unspecified in USA (SC), prior to May 2025